Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
Crossref DOI link: https://doi.org/10.1007/s40120-023-00489-2
Published Online: 2023-05-24
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weidlich, Diana
Servais, Laurent
Kausar, Imran
Howells, Ruth
Bischof, Matthias
Funding for this research was provided by:
Novartis Gene Therapies, Inc.
Text and Data Mining valid from 2023-05-24
Version of Record valid from 2023-05-24
Article History
Received: 25 February 2023
Accepted: 26 April 2023
First Online: 24 May 2023